MktsMarkets

Nuvation Bio Inc.
NYSE: NUVBKey statistics
NUVB News
Stories mentioning NUVB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 83,228 | 41,865 | 13,120 | 4,833 | 3,084 | 5,711 | 727.00 | 1,435 |
| Cost of Goods Sold | 3,349 | 2,576 | 2,094 | 4,216 | 1,515 | 1,347 | ||
| Gross Profit | 9,771 | 2,257 | 990.00 | 1,495 | (788.00) | 88.00 | ||
| Operating Expenses | ||||||||
| Research & Development | 35,047 | 34,297 | 28,846 | 27,362 | 24,601 | 29,299 | 27,731 | 29,247 |
| Sales General & Admin | 38,309 | 40,326 | 37,359 | 38,484 | 35,393 | 26,138 | 19,582 | 16,156 |
| Total Operating Expenses | 79,347 | 81,827 | 66,205 | 65,846 | 62,088 | 62,515 | 47,313 | 470,473 |
| Operating Income (Loss) | 3,881 | (34,037) | (56,434) | (63,589) | (59,004) | (53,942) | (48,101) | (470,385) |
| Interest Income | ||||||||
| Interest Expense | 5,121 | 132.00 | ||||||
| Other Expense | ||||||||
| Pretax Income | 5,397 | (36,592) | (55,792) | (59,007) | (53,236) | (49,445) | (41,210) | (462,492) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | 5,397 | (36,592) | (55,792) | (59,007) | (53,236) | (49,445) | (41,210) | (462,492) |
| Earnings Per Share (Basic) | 0.02 | (106.99) | (0.16) | (0.17) | (0.16) | (183.81) | (0.15) | (1.89) |
| Earnings Per Share (Diluted) | 0.01 | (106.99) | (0.16) | (0.17) | (0.16) | (183.81) | (0.15) | (1.89) |
| Weighted Average Shares Outstanding (Basic) | 347.00 | 342.00 | 342.00 | 341.00 | 339.00 | 269.00 | 274.00 | 245.00 |
| Weighted Average Shares Outstanding (Diluted) | 378.00 | 342.00 | 342.00 | 341.00 | 339.00 | 269.00 | 274.00 | 245.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NUVB
Nuvation Bio Inc. (NYSE: NUVB) is a stock listed on the New York Stock Exchange under the ticker symbol NUVB. It last traded at $4.16 (Nov 6, 2026, 4:00 PM ET), down 0.7% on the day. That gives Nuvation Bio a market capitalisation of $1.5B.
Over the past 52 weeks NUVB has traded between $3.98 and $9.75.
Revenue for the quarter ended Mar 31, 2026 was $83.2M; net income $5.4M. Revenue was up 2599% from $3.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $83.2M | $5.4M | 6.5% |
| Dec 31, 2025 | $41.9M | -$36.6M | -87.4% |
| Sep 30, 2025 | $13.1M | -$55.8M | -425.2% |
| Jun 30, 2025 | $4.8M | -$59.0M | -1220.9% |
From Nuvation Bio’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…